Mimedx (MDXG) Operating Income (2011 - 2026)
Mimedx (MDXG) reported Operating Income of -$16.0 million for Q1 2026, down 294.51% on a YoY basis from $8.3 million in Q1 2025, and down 176.14% sequentially from $21.1 million in Q4 2025.
Mimedx (MDXG) Operating Income (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Operating Income data on file, last reported at -$16.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 294.51% year-over-year to -$16.0 million; the trailing twelve-month figure through Mar 2026 stood at $39.6 million (down 26.58% YoY), and the FY2025 full-year result was $63.9 million, up 8.53% from the prior year.
- Operating Income fell to -$16.0 million in Q1 2026, from $21.1 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $23.4 million in Q2 2024 to a low of -$16.0 million in Q1 2026.
- A 5-year average of $7.6 million and a median of $11.1 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income sank 2250.24% in 2022 and jumped 3981.76% in 2024, its largest moves.
- Tracing MDXG's Operating Income over 5 years: stood at $11.3 million in 2022, then soared by 36.95% to $15.5 million in 2023, then retreated by 28.64% to $11.1 million in 2024, then jumped by 90.67% to $21.1 million in 2025, then sank by 176.14% to -$16.0 million in 2026.
- Business Quant data shows MDXG's Operating Income at -$16.0 million in Q1 2026, $21.1 million in Q4 2025, and $22.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -16.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.05 Mn |
| Dec 31, 2025 | 21.08 Mn |
| Sep 30, 2025 | 22.19 Mn |
| Jun 30, 2025 | 12.37 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 11.05 Mn |
| Sep 30, 2024 | 11.16 Mn |
| Jun 30, 2024 | 23.45 Mn |
| Mar 31, 2024 | 13.20 Mn |
| Dec 31, 2023 | 15.49 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 10.84 Mn |
| Mar 31, 2023 | -340,000.00 |
| Dec 31, 2022 | 11.31 Mn |
| Sep 30, 2022 | -7.10 Mn |
| Jun 30, 2022 | -9.64 Mn |
| Mar 31, 2022 | -9.30 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | -1.08 Mn |
| Jun 30, 2021 | -410,000.00 |